BSE Fundamental Analysis - Balance Sheet & Share Holding Pattern

SHREEGANESHREMEDIES01 Jan 1900

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in

SHREEGANESHREMEDIES01 Jan 1900

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
30-May-2023	D	Board approved: Recommended final dividend of Rs. 0.50/- per share of Rs. 10/- each (face value) for the year ended March 31, 2023. Dividend shall be paid on a pro-rata basis on partly paid equity shares in proportion to the face value paid-up. Record Date (As Per BSE Announcement Dated on 28/08/2023)	07-Sep-2023
06-May-2022	D	the Board of Directors of the Company at its meeting held today i.e. May 06, 2022 has recommended final dividend of Rs. 0.50/- per share of Rs. 10/- each (face value) for the year ended March 31, 2022 subject to approval of members in ensuing Annual General Meeting.	15-Sep-2022
03-May-2021	D	Shree Ganesh Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 03, 2021, inter alia, has recommended Final Dividend of Rs. 1.75/ - (Rupee One and Paisa Seventy Five Only) per Equity Share of Face Value of Rs. 10/- (Rupees Ten Only) each for the Financial Year ended March 31, 2021, subject to approval of the Shareholders at the ensuing Annual General Meeting of the Company.	08-Sep-2021
31-Jul-2020	D	The Board recommended Final Dividend of Re.1.50 / - (Rupee One and Paise Fifty Only) per Equity Share of Face Value of Rs.10 / - (Rupees Ten Only) each for the Financial Year ended March 31 , 2020, subject to approval of the Shareholders at the ensuing Annual General Meeting of the Company	01-Sep-2020
18-May-2019	D	BOARD APPROVES FINAL DIVIDEND OF RE. 1.25/- PER EQUITY SHARE OF FACE VALUE OF RS. 10/- EACH FOR THE YEAR ENDED MARCH 31, 2019.	22-Aug-2019
30-May-2018	D	Board Recommends Final Dividend of Re. 1 per share of Rs. 10/- each for the year ended March 31,2018	19-Sep-2018
18-Oct-2021	B	1:5 Bonus Issue of Equity Shares Trading Members of the Exchange are hereby informed that, Shree Ganesh Remedies Limited has fixed the record date for the purpose of Bonus Issue. The transactions in the equity shares of the company would be on an ex-bonus basis with effect from the under mentioned date: DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Shree Ganesh Remedies Limited (540737) RECORD DATE 02/11/2021 PURPOSE Issue of 1 (One) Bonus equity shares of Rs.10/- each for every 5 (Five) existing equity share of Rs.10/- each held. Ex-Bonus basis from Date & Sett. No. 01/11/2021 DR-147/2021-2022 (As Per BSE Notice Dated on 26.10.2021)	02-Nov-2021	1:5
28-Sep-2020	B	3:26 Bonus Issue of Equity Shares Trading Members of the Exchange are hereby informed that, SHREE GANESH REMEDIES LTD has fixed the record date for the purpose of Bonus Issue. The transactions in the equity shares of the Company would be on an ex-bonus basis with effect from the under mentioned date. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE SHREE GANESH REMEDIES LTD (540737) RECORD DATE 07/10/2020 PURPOSE Issue of 3 (Three) Bonus equity share of Rs.10/- each for every 26 (Twenty Six) existing equity share of Rs.10/- each held. Ex-Bonus basis from Date & Sett. No. 06/10/2020 DR-130/2020-2021 Trading Members of the Exchange are requested to take of it. (As Per BSE Notice Dated on 28.09.2020)	07-Oct-2020	3:26
24-Jan-2023	R	7:100 Right Issue of Equity Shares Trading Members of the Exchange are hereby informed that Shree Ganesh Remedies Limited has fixed Record date for the purpose of Rights Issue of Equity Shares. The transactions in the Equity Shares of the Company should be done on Ex-Rights basis with effect from the under mentioned date :- DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Shree Ganesh Remedies Limited (540737) RECORD DATE 03.02.2023 PURPOSE Issue of 07 (Seven) Equity Shares of Rs.10/- each for cash at a premium of Rs.215/- on Rights basis for every 100 (Hundred) Equity Shares held.* Ex-Right basis from Date & Sett. No. 03/02/2023 DR-712/2022-2023 * Terms of Payment of Issue Price of Rs.225/- - Rs. 135 per share i.e. 60% on application and remaining 40% on subsequent calls as may be decided by the Committee of the Board from time to time. Trading Members of the Exchange are requested to take note of it. (As Per BSE Bulletin Dated on 01.02.2023)	03-Feb-2023	7:100
23-Apr-2024	BC	Trading Members of the Exchange are hereby informed that they are permitted to trade in the under mentioned new securities of Shree Ganesh Remedies Ltd (Scrip Code: 540737) with effect from Wednesday	24-Apr-2024
15-Mar-2024	BC	Outcome of Board meeting Appointment of Company Secretary and Compliance Officer	15-Mar-2024
15-Mar-2024	BC	Outcome of Board meeting	15-Mar-2024
04-Mar-2024	BC	Updation of Registered Office Address of the Company	04-Mar-2024
05-Feb-2024	BC	Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve the Unaudited Financial Results for t	12-Feb-2024

Announcement Date30-May-2023

Ex Dividend Date07-Sep-2023

Dividend(%)5

Announcement Date06-May-2022

Ex Dividend Date15-Sep-2022

Dividend(%)5

Announcement Date03-May-2021

Ex Dividend Date08-Sep-2021

Dividend(%)18

Announcement Date31-Jul-2020

Ex Dividend Date01-Sep-2020

Dividend(%)15

Announcement Date18-May-2019

Ex Dividend Date22-Aug-2019

Dividend(%)12

Announcement Date30-May-2018

Ex Dividend Date19-Sep-2018

Dividend(%)10

Record Date01 Jan'1900

Ex-Rights Date01 Jan'1900

Premium(Rs.)215

Ratio7:100

Book Closure

Record Date	Split Date	Purpose
24-Apr-2024	-	Trading Members of the Exchange are hereby informed that they are permitted to trade in the under mentioned new securities of Shree Ganesh Remedies Ltd (Scrip Code: 540737) with effect from Wednesday
15-Mar-2024	-	Outcome of Board meeting Appointment of Company Secretary and Compliance Officer
15-Mar-2024	-	Outcome of Board meeting
04-Mar-2024	-	Updation of Registered Office Address of the Company
12-Feb-2024	-	Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve the Unaudited Financial Results for t

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Lupin Ltd ₹1,637.45(+21.50/1.33%)	1,637.45	+21.50	74,626.80	128.34	36.21	3.87
Ipca Laboratories Ltd ₹1,334.00(-4.50/-0.34%)	1,334.00	-4.50	33,844.14	90.83	61.44	5.45
J B Chemicals & Pharmaceuticals Ltd ₹1,906.65(+41.60/2.23%)	1,906.65	+41.60	29,590.22	77.48	58.44	11.03
Sanofi India Ltd ₹8,277.50(+3.35/0.04%)	8,277.50	+3.35	19,063.08	38.57	32.30	18.78
IOL Chemicals & Pharmaceuticals Ltd ₹396.50(-3.00/-0.75%)	396.50	-3.00	2,327.67	-2.77	13.49	1.46

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	27.97	33.42	26.72	29.33	21.99	21.26
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	27.97	33.42	26.72	29.33	21.99	21.26
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	1.11	0.80	0.73	0.44	1.40	0.73
Total Income	29.09	34.22	27.45	29.76	23.39	21.99
Total Expenditure	19.77	24.19	19.95	21.06	16.62	15.93
PBIDT	9.32	10.03	7.50	8.70	6.77	6.05
Interest	0.02	0.01	0.01	0.04	0.03	-0.14
PBDT	9.30	10.02	7.49	8.66	6.74	6.20
Depreciation	1.88	1.41	1.02	1.03	0.97	0.90
Tax	2.02	1.98	1.70	2.00	1.44	1.37
Deferred Tax	0.60	0.07	0.02	-0.23	-0.03	-0.01
Reported Profit After Tax	4.80	6.55	4.75	5.87	4.35	3.94
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	4.80	6.55	4.75	5.87	4.35	3.94

EPS (Unit Curr.)	3.84	5.32	3.86	4.78	3.56	3.28
EPS (Adj) (Unit Curr.)	3.84	5.32	3.86	4.78	3.53	3.26
Calculated EPS (Unit Curr.)	3.84	5.32	3.86	4.78	3.56	3.28
Calculated EPS (Adj) (Unit Curr.)	3.84	5.32	3.86	4.78	3.53	3.26
Calculated EPS (Ann.) (Unit Curr.)	15.35	21.30	15.44	19.11	14.23	13.11
Calculated EPS (Adj) (Ann.) (Unit Curr.)	15.35	21.30	15.44	19.11	14.13	13.02
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	12.51	12.31	12.31	12.28	12.23	12.01
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	33.32	30.01	28.07	29.66	30.79	28.46
PBDTM(%)	33.25	29.98	28.03	29.53	30.65	29.16
PATM(%)	17.16	19.60	17.78	20.01	19.78	18.53

Column	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
Gross Sales	21.13	16.97	12.63	15.37	13.26	11.52
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	21.13	16.97	12.63	15.37	13.26	11.52
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.88	0.44	1.11	0.16	0.54	0.45
Total Income	22.01	17.41	13.74	15.53	13.81	11.98
Total Expenditure	15.35	12.52	9.58	10.24	10.09	7.32
PBIDT	6.66	4.88	4.16	5.29	3.72	4.66
Interest	0.03	0.03	0.07	0.01	0.02	0.01
PBDT	6.62	4.86	4.09	5.28	3.70	4.65
Depreciation	0.99	0.95	0.82	1.23	0.22	0.64
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	1.45	0.90	0.94	1.33	0.49	0.86
Deferred Tax	-0.02	-0.01	0.00	-0.32	0.22	0.06
Reported Profit After Tax	4.20	3.02	2.34	3.03	2.77	3.09
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	4.20	3.02	2.34	3.03	2.77	3.09

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	4.20	3.02	2.34	3.03	2.77	3.09

EPS (Unit Curr.)	3.50	3.02	4.68	3.03	2.31	6.18
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	12.01	10.01	10.01	10.01	10.01	10.01

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	31.52	28.76	32.94	34.42	28.05	40.45
PBDTM(%)	31.33	28.64	32.38	34.35	27.90	40.36
PATM(%)	19.88	17.80	18.53	19.71	20.89	26.82

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	12.51	12.01	10.01	8.97	8.97	8.97
Reserves Total	76.43	49.57	40.00	33.12	24.85	19.70
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	88.94	61.58	50.01	42.09	33.82	28.67
Secured Loans	31.94	0.00	0.17	2.12	0.57	2.27
Unsecured Loans	1.57	0.00	0.04	0.20	0.18	0.09
Total Debt	33.51	0.00	0.21	2.32	0.75	2.36
Total Liabilities	122.45	61.58	50.22	44.41	34.57	31.03
APPLICATION OF FUNDS :
Gross Block	54.92	42.07	30.33	25.12	21.05	11.72
Less : Accumulated Depreciation	18.67	14.88	11.48	8.85	6.55	5.61
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	36.25	27.19	18.85	16.27	14.50	6.11
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	41.77	3.09	2.05	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.08	0.08	3.19	7.10	4.05	4.05
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	18.18	13.64	12.71	5.50	6.51	4.27
Sundry Debtors	27.92	18.38	13.33	16.63	9.72	5.73
Cash and Bank	11.15	3.88	3.47	1.75	1.00	8.52
Loans and Advances	7.05	9.00	5.36	3.88	4.58	5.93
Total Current Assets	64.30	44.91	34.87	27.77	21.81	24.45
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	14.53	9.47	6.21	3.85	3.90	1.79
Provisions	6.63	5.57	3.77	3.54	2.39	2.58
Total Current Liabilities	21.17	15.04	9.97	7.39	6.28	4.37
Net Current Assets	43.13	29.87	24.90	20.37	15.53	20.09
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.08	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.20	0.24	0.28	0.33	0.09
Net Deferred Tax	0.08	-0.20	-0.24	-0.28	-0.33	-0.09
Total Assets	121.31	60.04	48.75	43.46	33.75	30.16
Contingent Liabilities	4.17	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	3.88	3.47	1.75	0.99	6.46
Net Cash from Operating Activities	17.01	13.42	3.31	3.88	-5.22
Net Cash Used In Investing Activities	-53.57	-11.91	-0.94	-2.91	-0.08
Net Cash Used In Financing Activities	41.33	-1.09	-0.66	-0.21	-0.18
Net Inc./Dec In Cash And Cash Equivalents	4.77	0.42	1.71	0.76	-5.47
Cash And Cash Equivalents At End Of The Year	8.65	3.88	3.47	1.75	0.99

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

69.33%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

30.67%

**Promoter pledged shareholding 69.33%

About Shree Ganesh Remedies Ltd

Shree Ganesh Remedies Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 796.54 crores. It has reported a sales of Rs. 27.97 crores and a net profit of Rs. 4.8 crores for the quarter ended December 2018. The company management includes Chandubhai Kothia, Chandubhai Kothia,Gunjan Chandulal Kothia,Parth Chandulal Kothia,Priyam Surendra Shah,Jayesh Savjani,Vaishaliben Kanjibhai Vadodariya,Parul Sahani,Maulikkumar Sudani (Shree Ganesh Remedies Ltd) among others.

Chairman

Chandubhai Kothia

Registered office

Plot No 6011,GIDC,Ankleshwar,Gujarat,393002

FAX :91-2646-226422

Background

Incorporation Year1995

Face Value₹10

Market Lot1

How to buy shares on nse?

To buy shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the share price today?

The shares price on nse is Rs.0 today.

What is the market cap of shares on ?

The company has a market capitalization of Rs.0.00Cr

What is the PE & PB ratio of shares ?

PE is 0 and PB is 0

What is the 52 Week High and Low of shares?

stock price high: Rs.0 stock price low: Rs.0